Piper Jaffray Companies assumed coverage on shares of Teleflex Incorporated (NYSE:TFX) in a research report report published on Friday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a $295.00 target price on the medical technology company’s stock.
Other equities analysts have also issued reports about the company. Deutsche Bank AG reiterated a buy rating and issued a $238.00 target price (up from $220.00) on shares of Teleflex in a research note on Wednesday, August 9th. Jefferies Group LLC restated a buy rating and set a $253.00 price target (up from $230.00) on shares of Teleflex in a research note on Wednesday, August 9th. Needham & Company LLC restated a buy rating on shares of Teleflex in a research note on Friday, August 4th. Zacks Investment Research upgraded Teleflex from a hold rating to a buy rating and set a $233.00 price target for the company in a research note on Friday, August 25th. Finally, Stephens restated a buy rating and set a $270.00 price target (up from $230.00) on shares of Teleflex in a research note on Monday, September 25th. One analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company’s stock. Teleflex has a consensus rating of Hold and a consensus price target of $274.44.
Teleflex (TFX) opened at $256.94 on Friday. The company has a market capitalization of $11,392.51, a price-to-earnings ratio of 31.26, a P/E/G ratio of 2.17 and a beta of 1.05. Teleflex has a 12 month low of $141.92 and a 12 month high of $263.97. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.01 by $0.11. The firm had revenue of $534.70 million during the quarter, compared to analyst estimates of $522.94 million. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The business’s quarterly revenue was up 17.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.80 earnings per share. equities analysts predict that Teleflex will post 8.32 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Piper Jaffray Companies Begins Coverage on Teleflex Incorporated (TFX)” was first reported by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/piper-jaffray-companies-begins-coverage-on-teleflex-incorporated-tfx/1774630.html.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Wednesday, November 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.53%. The ex-dividend date is Tuesday, November 14th. Teleflex’s payout ratio is 24.82%.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $211.75, for a total value of $42,350.00. Following the completion of the sale, the director now owns 8,080 shares of the company’s stock, valued at $1,710,940. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 600 shares of company stock valued at $138,162 in the last ninety days. Company insiders own 2.39% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of TFX. Toronto Dominion Bank boosted its position in shares of Teleflex by 14.5% in the second quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after buying an additional 70 shares during the period. Advisory Services Network LLC boosted its position in shares of Teleflex by 933.8% in the second quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock worth $172,000 after buying an additional 747 shares during the period. Cornerstone Capital Management Holdings LLC. purchased a new position in Teleflex in the second quarter valued at about $175,000. Campbell & CO Investment Adviser LLC purchased a new position in Teleflex in the second quarter valued at about $200,000. Finally, Calamos Advisors LLC purchased a new position in Teleflex in the second quarter valued at about $206,000. 90.45% of the stock is owned by institutional investors.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with our FREE daily email newsletter.